| Secondary |
| Dysmenorrhoea |
21.6% |
| Product Used For Unknown Indication |
16.2% |
| Foetal Exposure During Pregnancy |
10.8% |
| Drug Use For Unknown Indication |
8.1% |
| Pain |
8.1% |
| Arrhythmia |
5.4% |
| Exposure During Breast Feeding |
5.4% |
| Renal Failure Chronic |
5.4% |
| Cardiac Disorder |
2.7% |
| Dental Care |
2.7% |
| Facial Operation |
2.7% |
| Headache |
2.7% |
| Migraine |
2.7% |
| Prophylaxis |
2.7% |
| Psoriatic Arthropathy |
2.7% |
|
| Intentional Drug Misuse |
12.5% |
| Wrong Drug Administered |
12.5% |
| Asthenia |
6.3% |
| Completed Suicide |
6.3% |
| Drug Exposure During Pregnancy |
6.3% |
| Drug Ineffective |
6.3% |
| Drug Toxicity |
6.3% |
| Encephalopathy |
6.3% |
| Jaundice Neonatal |
6.3% |
| Live Birth |
6.3% |
| Muscle Spasms |
6.3% |
| Peritoneal Effluent Abnormal |
6.3% |
| Tendonitis |
6.3% |
| Urinary Retention |
6.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.7% |
| Rheumatoid Arthritis |
10.6% |
| Depression |
7.1% |
| Multiple Sclerosis |
6.2% |
| Crohn's Disease |
5.4% |
| Pain |
5.4% |
| Drug Use For Unknown Indication |
4.8% |
| Abnormal Behaviour |
2.9% |
| Hypertension |
2.8% |
| Premedication |
2.8% |
| Ankylosing Spondylitis |
2.5% |
| Psoriatic Arthropathy |
2.5% |
| Craniocerebral Injury |
2.3% |
| Post-traumatic Stress Disorder |
2.3% |
| Relaxation Therapy |
2.3% |
| Anti-infective Therapy |
1.4% |
| Sedation |
1.4% |
| Back Pain |
0.9% |
| Haemorrhoids |
0.9% |
| Infection Prophylaxis |
0.9% |
|
| Progressive Multifocal Leukoencephalopathy |
11.3% |
| Fall |
8.1% |
| Cerebrovascular Accident |
6.5% |
| Fistula |
4.8% |
| Foot Operation |
4.8% |
| Hallucination |
4.8% |
| Knee Arthroplasty |
4.8% |
| Monoclonal Gammopathy |
4.8% |
| Multiple Sclerosis Relapse |
4.8% |
| Musculoskeletal Stiffness |
4.8% |
| Nausea |
4.8% |
| Nuclear Magnetic Resonance Imaging Abnormal |
4.8% |
| Sepsis |
4.8% |
| Surgery |
4.8% |
| Tardive Dyskinesia |
4.8% |
| Blood Cholesterol Increased |
3.2% |
| Breast Calcifications |
3.2% |
| Cerebral Haemangioma |
3.2% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Fatigue |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Pain Management |
50.0% |
|
|
